Clinical impact and cost-effectiveness of updated 2023/24 COVID-19 mRNA vaccination in high-risk populations in the United States
media
posted on 2025-04-03, 07:54 authored by Adis Journals on behalf of:, Ekkehard Beck, Keya Joshi, Mariia Dronova, Ewelina Paterak, Van Hung Nguyen, Hagit Kopel, James Mansi, Nicolas Van De VeldeThe above graphical abstract represents the opinions of the authors . For a full list of declarations, including funding and author disclosure statements, and copyright information, please see the full text online (see “read the peer-reviewed publication” opposite).
